Vaccines for epidemic diseases

Apply for a share of up to £10 million to develop further research into vaccines and vaccine technologies. This will help tackle understudied infectious diseases with the potential to cause future epidemics.

The aim of this competition is to develop further research into vaccines and vaccine technologies to tackle understudied infectious diseases which could have the potential to cause future epidemics, as identified by the UK Vaccine Network and Disease X.

This is a Small Business Research Initiative (SBRI). The competition is run by the Official Development Assistance (ODA) and funded by the Department of Health and Social Care (DHSC).

Proposals can address any part of the pre-clinical, non-clinical, manufacturing, or clinical pathways within a one year period. This will allow for technologies to be progressed later in the developmental stages.

All proposals must meet ODA requirements for funding.

Applicants should consider:

  • Ease and speed of manufacture
  • Practical use in low to middle income countries (LMIC) – needle-free administration, for example
  • Temperature stability
  • Single dose delivery, or low number of boosts required
  • Length of protection
  • Vaccine platforms that can be rapidly adapted for new or re-emerging diseases
  • Vaccines that protect against several strains of a single pathogen, or against several pathogens

A total of up to £10 million, inclusive of VAT, is allocated for this competition.


Your project must start on 1 April 2022 and finish by 31 March 2023. It should last for up to 12 months and cost no more than £500,000 in total (inclusive of VAT).

The competition will be open for applications from 11 October until 11am on 10 November 2021.

How to get involved

Find more information and get involved on the GOV.UK website.